Publications by authors named "Isabelle Tigaud"

Claim this Profile
C
Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Amine Belhabri, Mael Heiblig, Stephane Morisset, Liliana Vila, Clémence Santana, Isabelle Tigaud

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Marie Balsat, Vincent Alcazer, Gabriel Etienne, Françoise Huguet, Marc Berger, Isabelle Tigaud

Leuk Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study.
Grégoire Le Meur, Adriana Plesa, Marie-Virginie Larcher, Gaëlle Fossard, Fiorenza Barraco, Isabelle Tigaud

Transplant Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-Derived Leukemia in a Recipient of Double-Unit Cord Blood Transplantation for Acute Myeloid Leukemia: A Case Study and Literature Review.
Adriana Plesa, Isabelle Tigaud, Sandrine Hayette, Christophe Roumier, Xavier Thomas

Oncol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, Laetitia Largeaud, Vincent Fregona, Isabelle Tigaud

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
Adriana Plesa, Christophe Roumier, Joris Gutrin, Marie-Virginie Larcher, Marie Balsat, Isabelle Tigaud

Leuk Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies.
Sandrine Hayette, Béatrice Grange, Maxime Vallee, Claire Bardel, Sarah Huet, Isabelle Tigaud

Hemasphere· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-ALL With t(5;14)(q31;q32); Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar -Rearranged B-ALL.
Benjamin Fournier, Estelle Balducci, Nicolas Duployez, Emmanuelle Clappier, Wendy Cuccuini, Isabelle Tigaud

Front Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Audrey Bidet, Stéphanie Dulucq, Thomas Smol, Alice Marceau-Renaut, Stéphane Morisset, Isabelle Tigaud

Haematologica· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line.
Stephanie Dulucq, Gabriel Etienne, Stephane Morisset, Emilie Klein, Claudine Chollet, Isabelle Tigaud

Ann Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.
Maël Heiblig, Hélène Labussière-Wallet, Franck Emmanuel Nicolini, Mauricette Michallet, Sandrine Hayette, Isabelle Tigaud

Cancers (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life.
Sarah Huet, Etienne Paubelle, Camille Lours, Beatrice Grange, Lucien Courtois, Isabelle Tigaud

Blood· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.
Elodie Collinge, Isabelle Tigaud, Brigitte Balme, Luc-Marie Gerland, Pierre Sujobert

Medicine (Baltimore)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia.
Adriana Plesa, Charles Dumontet, Eve Mattei, Ines Tagoug, Sandrine Hayette, Isabelle Tigaud

World J Stem Cells· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.
Marina Lafage-Pochitaloff, Laurence Baranger, Mathilde Hunault, Wendy Cuccuini, Christine Lefebvre, Isabelle Tigaud

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.
Aminetou Mint Mohamed, Marie Balsat, Catherine Koering, Delphine Maucort-Boulch, Nicolas Boissel, Isabelle Tigaud

Leuk Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature.
Adrien Quintela, Pierre Sujobert, Isabelle Tigaud, Sandrine Hayette, Martine Ffrench

Oncol Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Maël Heiblig, Caroline Le Jeune, Mohamed Elhamri, Marie Balsat, Isabelle Tigaud

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.
Maël Heiblig, Etienne Paubelle, Adriana Plesa, Marie-Oldine Geay, Delphine Manzoni, Isabelle Tigaud

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Virginie Eclache, Marina Lafage-Pochitaloff, Christine Lefebvre, Dominique Penther, Sophie Raynaud, Isabelle Tigaud

Ann Biol Clin (Paris)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.
Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco

Mediterr J Hematol Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia.
Jihane Fattoum, Giovanna Cannas, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa

Clin Lymphoma Myeloma Leuk· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.
Sarah Huet, Pascale Cony-Makhoul, Maël Heiblig, Isabelle Tigaud, Sophie Gazzo

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher percentage of CD34 + CD38- cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia.
Adriana Plesa, Mohamed Elhamri, Gilles Clapisson, Eve Mattei, Sophie Gazzo, Isabelle Tigaud

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.
Jonathan Bond, Aurélie Bergon, Amandine Durand, Isabelle Tigaud, Xavier Thomas

Blood· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis